AstraZeneca leaps on cholesterol drug ruling – MarketWatch

Pin It

AstraZeneca leaps on cholesterol drug ruling
MarketWatch
LONDON (MarketWatch) — AstraZeneca's London-listed shares leaped as much as 11% on Wednesday after a judge ruled in favor of the company's patents on a key cholesterol drug. On Tuesday, a US district court said the
UK Stocks Advance; AstraZeneca Leads Gain in FTSE 100 IndexBusinessWeek
AstraZeneca gives FTSE a fillip, adding 10% after Crestor rulingThe Guardian
AstraZeneca, WebTech, Vermillion, Playboy, LVMH: Intellectual PropertyBloomberg
The Associated Press –Financial Times –Wall Street Journal
all 213 news articles »

View full post on Business – Google News

Leave a Reply

*